<table style='font-family:Arial;padding:40px;'><tr><td colspan='2' style='font-weight:bold;font-size:150%;padding-bottom:15px;'>Dr. James McNess</td</tr><tr><td colspan='2' style='font-weight:bold;font-size:120%;padding-bottom:15px;'>Surgical Audit</td></tr><tr><td colspan='2' style='padding-bottom:30px;'> <span style='font-weight:bold;'>Audit Interval:</span> From <span style='font-style:italic; color:#ff0000'> 24/06/14 </span> to <span style='font-style:italic; color:#ff0000; '>02/07/14</span > </td></tr > <tr style='font-weight:bold' valign='top'><td style='width:75px;padding-top:35px;padding-bottom:20px;' > CI 1.1 </td><td style='padding-top:30px;padding-bottom:20px;'>Gynaecological surgery for benign disease ? unplanned intra- or post-operative blood transfusion</td > </tr><tr><td></td><td style='border-bottom:1px solid #000000;padding-bottom:5px;color:#222222;'>Number of patients receiving an unplanned intra-operative or post-operative blood transfusion during their hospital admission for any type of gynaecological surgery for benign disease. <span style='font-style:italic;'>(16)</span></td></tr><tr><td></td><td style='padding-top:5px;color:#222222;'>Number of patients undergoing gynaecological surgery for benign disease  <span style='font-style:italic;'>(19)</span></td></tr><tr style='padding-bottom:60px;'><td style='color:#ff0000;text-align:right;padding-top:15px;' colspan='2'>16/19 = <span style='font-weight:bold;'>84.21% </span></td></tr><tr style='font-weight:bold' valign='top'><td style='width:75px;padding-top:35px;padding-bottom:20px;' > CI 2.1 </td><td style='padding-top:30px;padding-bottom:20px;'>Gynaecological surgery - injury to a major viscus with repair</td > </tr><tr><td></td><td style='border-bottom:1px solid #000000;padding-bottom:5px;color:#222222;'>Number of patients suffering injury to a major viscus with repair, during a gynaecological operative procedure or subsequently up to 2 weeks post-operatively. <span style='font-style:italic;'>(2)</span></td></tr><tr><td></td><td style='padding-top:5px;color:#222222;'>Number of patients undergoing gynaecological surgery for benign disease.  <span style='font-style:italic;'>(19)</span></td></tr><tr style='padding-bottom:60px;'><td style='color:#ff0000;text-align:right;padding-top:15px;' colspan='2'>2/19 = <span style='font-weight:bold;'>10.53% </span></td></tr><tr style='font-weight:bold' valign='top'><td style='width:75px;padding-top:35px;padding-bottom:20px;' > CI 3.1 </td><td style='padding-top:30px;padding-bottom:20px;'>Ectopic pregnancy managed laparoscopically</td > </tr><tr><td></td><td style='border-bottom:1px solid #000000;padding-bottom:5px;color:#222222;'>Number of patients having laparoscopic management of an ectopic pregnancy. <span style='font-style:italic;'>(8)</span></td></tr><tr><td></td><td style='padding-top:5px;color:#222222;'>Number of patients presenting with an ectopic pregnancy who are managed surgically.  <span style='font-style:italic;'>(14)</span></td></tr><tr style='padding-bottom:60px;'><td style='color:#ff0000;text-align:right;padding-top:15px;' colspan='2'>8/14 = <span style='font-weight:bold;'>57.14% </span></td></tr><tr style='font-weight:bold' valign='top'><td style='width:75px;padding-top:35px;padding-bottom:20px;' > CI 4.1 </td><td style='padding-top:30px;padding-bottom:20px;'>Thromboprophylaxis for major gynaecological surgery</td > </tr><tr><td></td><td style='border-bottom:1px solid #000000;padding-bottom:5px;color:#222222;'>Number of patients undergoing major gynaecological surgery who receive thromboprophylaxis according to hospital guidelines. <span style='font-style:italic;'>(1)</span></td></tr><tr><td></td><td style='padding-top:5px;color:#222222;'>Number of patients undergoing major gynaecological surgery.  <span style='font-style:italic;'>(19)</span></td></tr><tr style='padding-bottom:60px;'><td style='color:#ff0000;text-align:right;padding-top:15px;' colspan='2'>1/19 = <span style='font-weight:bold;'>5.26% </span></td></tr><tr style='font-weight:bold' valign='top'><td style='width:75px;padding-top:35px;padding-bottom:20px;' > CI 4.2 </td><td style='padding-top:30px;padding-bottom:20px;'>Re-admission for venous thromboembolism within 28 days</td > </tr><tr><td></td><td style='border-bottom:1px solid #000000;padding-bottom:5px;color:#222222;'>Number of patients who develop or are re-admitted with venous thromboembolism (VTE) within 28 days of major gynaecological surgery. <span style='font-style:italic;'>(6)</span></td></tr><tr><td></td><td style='padding-top:5px;color:#222222;'>Number of patients undergoing major gynaecological surgery.  <span style='font-style:italic;'>(19)</span></td></tr><tr style='padding-bottom:60px;'><td style='color:#ff0000;text-align:right;padding-top:15px;' colspan='2'>6/19 = <span style='font-weight:bold;'>31.58% </span></td></tr><tr style='font-weight:bold' valign='top'><td style='width:75px;padding-top:35px;padding-bottom:20px;' > CI 5.1 </td><td style='padding-top:30px;padding-bottom:20px;'>Use of mesh repair for pelvic organ prolapse</td > </tr><tr><td></td><td style='border-bottom:1px solid #000000;padding-bottom:5px;color:#222222;'>Number of patients having mesh repair. <span style='font-style:italic;'>(4)</span></td></tr><tr><td></td><td style='padding-top:5px;color:#222222;'>Number of patients having a repair for pelvic organ prolapse.  <span style='font-style:italic;'>(17)</span></td></tr><tr style='padding-bottom:60px;'><td style='color:#ff0000;text-align:right;padding-top:15px;' colspan='2'>4/17 = <span style='font-weight:bold;'>23.53% </span></td></tr><tr style='font-weight:bold' valign='top'><td style='width:75px;padding-top:35px;padding-bottom:20px;' > CI 6.1 </td><td style='padding-top:30px;padding-bottom:20px;'>Surgical intervention for menorrhagia</td > </tr><tr><td></td><td style='border-bottom:1px solid #000000;padding-bottom:5px;color:#222222;'>Number of patients undergoing a hysterectomy for menorrhagia. <span style='font-style:italic;'>(6)</span></td></tr><tr><td></td><td style='padding-top:5px;color:#222222;'>Number of patients undergoing gynaecological surgery to treat menorrhagia.  <span style='font-style:italic;'>(18)</span></td></tr><tr style='padding-bottom:60px;'><td style='color:#ff0000;text-align:right;padding-top:15px;' colspan='2'>6/18 = <span style='font-weight:bold;'>33.33% </span></td></tr></table>
				